Aggrenox Prevention of Access Stenosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Catherine Meyers, M.D.
NIDDK - Telephone: 301-451-4901; Email: meyersc@extra.niddk.nih.gov
Study Director - John W Kusek, Ph.D.
NIDDK - Telephone: 301-594-7717; Email: kusekj@ep.niddk.nih.gov
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of Iowa
Iowa City, Iowa, United States
- Maine Medical Center
Portland, Maine, United States
- Boston University Medical Center
Boston, Massachusetts, United States
- Washington University
St Louis, Missouri, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Wake Forest University
Winston-Salem, North Carolina, United States
- Vanderbilt University
Nashville, Tennessee, United States
- University of Texas Southwestern
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jan 2003
- Primary completion
- 31 Jan 2008
- Completion
- 31 Jan 2008
- Last update posted
- 19 Sept 2017
- Registered enrollment
- 649
- Registry id
- NCT00067119
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.